<--- Back to Details
First PageDocument Content
Centers for Disease Control and Prevention / Health in India / HIV/AIDS in the United States / National Center for HIV/AIDS /  Viral Hepatitis /  STD /  and TB Prevention / Tuberculosis treatment / National Institutes of Health / Tuberculosis in China / John E. Fogarty International Center / Medicine / Tuberculosis / Health
Date: 2015-01-12 12:01:39
Centers for Disease Control and Prevention
Health in India
HIV/AIDS in the United States
National Center for HIV/AIDS
Viral Hepatitis
STD
and TB Prevention
Tuberculosis treatment
National Institutes of Health
Tuberculosis in China
John E. Fogarty International Center
Medicine
Tuberculosis
Health

Microsoft Word - Final_Forum Proceedings.doc

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 1,98 MB

Share Document on Facebook

Similar Documents

For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte

DocID: 1vkmw - View Document

PRESS RELEASE Adequate treatment essential to stop TB across Europe – new ECDC/WHO report Stockholm/Copenhagen, 19 MarchOverpatients are estimated to fall sick with tuberculosis (TB) every day across Euro

DocID: 1saSR - View Document

JOINT PRESS RELEASE New ECDC-WHO report: tuberculosis on the retreat in Europe. Concerns about drugresistant TB and treatment failure. Stockholm/Copenhagen, 19 March 2012

DocID: 1rHnT - View Document

Tuberculosis / Medicine / Clinical medicine / Health / Tuberculosis management / Tuberculosis diagnosis / DOTS / World Tuberculosis Day / TB Alert / Tuberculosis in India

15 | P a g e Multiple healthcare Seeking behaviors of new Smear positive pulmonary tuberculosis patients attending a diagnosis and treatment center of Bafoussam- Cameroon ABSTRACT FABRICE NEMBOT DJOUMA , ARMELLE VIVIAN

DocID: 1qzgC - View Document

Tuberculosis / Clinical medicine / Health / Medicine / Multi-drug-resistant tuberculosis / Bedaquiline / Tuberculosis management / Latent tuberculosis

Embargoed: 12 May – 1130 hrs CEST WORLD HEALTH ORGANIZATION RECOMMENDS SHORTENED NINE-MONTH TREATMENT REGIMEN FOR MDR-TB PATIENTS

DocID: 1q2l5 - View Document